Patents by Inventor Stéphane Bertagnoli

Stéphane Bertagnoli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated strain of myxoma virus for use as an oncolytic drug
    Patent number: 8613915
    Abstract: The invention relates to the use of an attenuated vaccinal strain of Myxoma virus, in particular the SG33 strain, as an oncolytic agent.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: December 24, 2013
    Assignees: Institute National de la Recherche Agronomique, ECOLE Nationale Veterinaire Toulouse
    Inventors: Stéphane Bertagnoli, Magalie Gretillat, Jacqueline Gelfi, Christelle Camus-Bouclainville
  • Attenuated Strain of Myxoma Virus for Use as an Oncolytic Drug
    Publication number: 20120141427
    Abstract: The invention relates to the use of an attenuated vaccinal strain of Myxoma virus, in particular the SG33 strain, as an oncolytic agent.
    Type: Application
    Filed: June 11, 2010
    Publication date: June 7, 2012
    Inventors: Stéphane Bertagnoli, Magalie Gretillat, Jacqueline Gelfi, Christelle Camus-Bouclainville
  • LEPORIPOXVIRUS-DERIVED VACCINE VECTORS
    Publication number: 20110052626
    Abstract: The invention relates to modified leporipoxyinises expressing a chimeric envelope protein resulting from the fusion of an envelope protein of mature intracellular virions or of an envelope protein of enveloped extracellular virions, with an exogenous protein. These modified leporipoxviruses can be used in particular for obtaining vaccines.
    Type: Application
    Filed: December 3, 2008
    Publication date: March 3, 2011
    Inventors: Stéphane Bertagnoli, Béatrice Pignolet, Jacqueline Gelfi, Christelle Camus-Bouclainville